{"name": "Versartis",
 "permalink": "versartis",
 "crunchbase_url": "http://www.crunchbase.com/company/versartis",
 "homepage_url": "http://www.versartis.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2008,
 "founded_month": 12,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "Therapeutics Protein Developer",
 "created_at": "Wed Jun 17 18:19:24 UTC 2009",
 "updated_at": "Tue Mar 26 13:04:56 UTC 2013",
 "overview": "\u003Cp\u003EVersartis, Inc. is a biotechnology company developing therapeutic proteins for the treatment of endocrine disorders. \u003C/p\u003E\n\n\u003Cp\u003EThe company was founded in December 2008 as a joint venture between Amunix Inc. and Index Ventures. The founders are Jeffrey Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger and Joshua Silverman.  Versartis is developing new therapeutic proteins utilizing the novel half-life extension technology, XTEN.  Versartis owns and develops the novel drug candidates that it has licensed from Amunix.\u003C/p\u003E\n\n\u003Cp\u003EVersartis is headquartered in Redwood City, California, USA.  Our lead program, VRS-317, has recently completed enrollment in a multi-center Phase 1 study in adult patients with growth hormone deficiency. The company is staffed with drug development experts and utilizes external contract services to execute on its product development plans in a capital-efficient manner.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       41],
      "assets/images/resized/0004/9154/49154v1-max-150x150.png"],
     [[250,
       69],
      "assets/images/resized/0004/9154/49154v1-max-250x250.png"],
     [[262,
       73],
      "assets/images/resized/0004/9154/49154v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$57M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.fiercebiotech.com/story/start-versartis-snags-11m-upcoming-trials/2009-06-02?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0",
    "source_description": "Start-up Versartis snags $11M for upcoming trials",
    "raised_amount": 11000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 6,
    "funded_day": 2,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Index Ventures",
         "permalink": "index-ventures",
         "image":
          {"available_sizes":
            [[[150,
               68],
              "assets/images/resized/0005/1550/51550v1-max-150x150.png"],
             [[156,
               71],
              "assets/images/resized/0005/1550/51550v1-max-250x250.png"],
             [[156,
               71],
              "assets/images/resized/0005/1550/51550v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.versartis.com/content/newsandevents/releases/021611.htm",
    "source_description": "Versartis Completes $21 Million Series B Financing",
    "raised_amount": 21000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 2,
    "funded_day": 16,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Advent Venture Partners",
         "permalink": "advent-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0001/6550/16550v3-max-150x150.png"],
             [[250,
               100],
              "assets/images/resized/0001/6550/16550v3-max-250x250.png"],
             [[450,
               181],
              "assets/images/resized/0001/6550/16550v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Index Ventures",
         "permalink": "index-ventures",
         "image":
          {"available_sizes":
            [[[150,
               68],
              "assets/images/resized/0005/1550/51550v1-max-150x150.png"],
             [[156,
               71],
              "assets/images/resized/0005/1550/51550v1-max-250x250.png"],
             [[156,
               71],
              "assets/images/resized/0005/1550/51550v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://www.fiercebiotech.com/story/versartis-pockets-25m-c-round-it-looks-phii-growth-hormone-study/2013-01-15?utm_source=rss\u0026utm_medium=rss",
    "source_description": "Versartis pockets $25M C round as it looks to PhII growth hormone study",
    "raised_amount": 25000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 1,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Aisling Capital",
         "permalink": "aisling-capital",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0004/6625/46625v1-max-150x150.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-250x250.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Index Ventures",
         "permalink": "index-ventures",
         "image":
          {"available_sizes":
            [[[150,
               68],
              "assets/images/resized/0005/1550/51550v1-max-150x150.png"],
             [[156,
               71],
              "assets/images/resized/0005/1550/51550v1-max-250x250.png"],
             [[156,
               71],
              "assets/images/resized/0005/1550/51550v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Advent Venture Partners",
         "permalink": "advent-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0001/6550/16550v3-max-150x150.png"],
             [[250,
               100],
              "assets/images/resized/0001/6550/16550v3-max-250x250.png"],
             [[450,
               181],
              "assets/images/resized/0001/6550/16550v3-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Corporate Headquarters",
    "address1": "303 Twin Dolphin Drive",
    "address2": "Suite 600",
    "zip_code": "94065",
    "city": "Redwood City",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.523194,
    "longitude": -122.259179}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}